This page holds a finished NR 606 Week 6 augmentation rationale, presented section by section, with the comparative argument marked wherever the decision is defended. Searches like "nr 606 week 6 assignment example", "nr606 week 6 sample" and "nr 606 week 6 example" land here.
What a finished NR 606 Week 6 augmentation rationale looks like
The rationale that scores is comparative all the way through. Adding keeps a gain that is real but modest, and pays for it in burden, in interactions and in never knowing afterwards which agent is doing the work. Switching abandons the partial benefit and accepts a gap during the change, in exchange for a simpler plan and a cleaner answer later. Holding costs time, which for this patient may be the most expensive item of the three. A strong paper prices all three and then chooses. Weak ones argue only for the option they picked, which reads persuasive on its own and thin the moment a reader asks what was given up.
How a NR 606 Week 6 example is structured
The current state opens it: what the existing treatment achieved, at what dose, over what period, and what is still outstanding. The three options are then named together, before any of them is developed, so the reader sees the field. Each is costed in turn with the same measures applied, which is what makes the comparison hold rather than merely appear. The choice follows, with the strongest argument for the runner-up stated fairly rather than in a weakened form, since a straw alternative discredits the whole section. Evidence sits with the option it supports. Monitoring closes the document, written so the writer will know within a stated interval whether this was the right call. The three costings are kept parallel in length as well as in measure, since an option given half a paragraph has effectively been dismissed.
Where the treatment stands
What the current regimen achieved and what it left, established before options are opened, because the comparison is measured against that baseline.
Three roads named together
Add, switch or hold, put on the table at the same time so the decision reads as a choice rather than as a single advocacy piece.
The price of adding
Burden, interaction risk and the loss of attribution, since two active agents make it hard to say afterwards which one earned the improvement.
The price of switching
The partial gain surrendered, the gap during a cross-taper, and the possibility of ending with less than the patient already had.
The price of holding
Time, which is a real cost when someone is functioning below where they need to be and has already waited through one full trial.
The choice and the runner-up
A decision stated plainly with the best case for the option not taken represented honestly, since a weakened alternative undermines the argument.
Where marks go in NR 606 Week 6
The heaviest loss is the one-sided rationale: a thorough case for the chosen option with the other two mentioned and never costed. Second is the straw alternative, where switching or holding appears in a form nobody would defend, which tells a reader the comparison was decorative. Third is a decision with no attribution plan, adding a second agent and leaving no way to learn later which one worked. Then: the partial response treated as worthless, interaction and burden waved through in a clause, evidence stacked in one block instead of sitting with the option it supports, and monitoring written with no interval attached, so nothing about this decision can be judged on schedule.
Get a NR 606 Week 6 example written to your instructions
Send the Week 6 instructions and the case from your classroom, with your section's rubric if one is posted, and a custom example is written to that material and returned inside 24 to 48 hours. The first one is free. Name the option you are leaning toward and the sample will cost all three against it.
NR 606 Week 6 questions, answered
Does the paper have to recommend augmenting?
No. The genre names one of the three options and the assignment usually asks for a defended decision rather than a predetermined one. Switching and holding both win on the right facts, and a paper that argues for either against a fair comparison scores as well as one that adds. What loses marks is arriving at any of the three without having priced the others.
How do I handle the attribution problem?
Name it and plan around it. Once two agents are running, later improvement cannot be assigned cleanly, which matters when something has to be simplified or stopped. Strong papers say how they will limit the damage: changing one thing at a time, holding other variables steady across the interval, and setting a point where the added agent gets reassessed rather than left in place indefinitely.
Where does non-medication treatment fit?
Usually as one of the additions being priced, and it belongs in the same comparison rather than in a paragraph of its own at the end. Access, cost, scheduling and the patient's willingness are legitimate costs to weigh openly. A rationale that recommends therapy without addressing whether this particular patient can actually get to it is incomplete in a way instructors notice.